Innovation at the Intersection of Clinical Trials and Real-World Data Science to Advance Patient Care

Clinical and Translational Science
Brandon SwiftPravin R Jadhav

Abstract

While efficacy and safety data collected from randomized clinical trials are the evidentiary standard for determining market authorization, this alone may no longer be sufficient to address the needs of key stakeholders (regulators, providers, and payers) and guarantee long-term success of pharmaceutical products. There is a heightened interest from stakeholders on understanding the use of real-world evidence (RWE) to substantiate benefit-risk assessment and support the value of a new drug. This review provides an overview of real-world data (RWD) and related advances in the regulatory framework, and discusses their impact on clinical research and development. A framework for linking drug development decisions with the value proposition of the drug, utilizing pharmacokinetic-pharmacodynamic-pharmacoeconomic models, is introduced. The summary presented here is based on the presentations and discussion at the symposium entitled Innovation at the Intersection of Clinical Trials and Real-World Data to Advance Patient Care at the American Society for Clinical Pharmacology and Therapeutics (ASCPT) 2017 Annual Meeting.

References

May 25, 2007·Clinical Pharmacology and Therapeutics·R L LalondeR Miller
Oct 3, 2008·International Journal of Technology Assessment in Health Care·Susanne Hartz, Jürgen John
Jul 29, 2009·The New England Journal of Medicine·Richard PlattMark McClellan
Jun 15, 2010·Journal of Medical Internet Research·Paul WicksJames Heywood
Jul 2, 2010·Clinical Pharmacology and Therapeutics·T H Grasela, R Slusser
Jul 9, 2010·Clinical Pharmacology and Therapeutics·N HolfordB A Ploeger
Jan 27, 2012·Indian Journal of Urology : IJU : Journal of the Urological Society of India·Roger L Sur, Philipp Dahm
Apr 17, 2013·Clinical Pharmacology and Therapeutics·P A MilliganR L Lalonde
Feb 18, 2014·British Journal of Clinical Pharmacology·Holly Kimko, José Pinheiro
Apr 15, 2014·International Journal of Clinical Pharmacology and Therapeutics·Lokesh JainJogarao Gobburu
Apr 18, 2014·Clinical Pharmacology and Therapeutics·B Vrijens, J Urquhart
May 14, 2014·Journal of the American Medical Informatics Association : JAMIA·Rachael L FleurenceJeffrey S Brown
Sep 11, 2014·Health Economics·Penny Breeze, Alan Brennan
Nov 12, 2014·Journal of Clinical Pharmacology·Michael J Fossler
Aug 8, 2015·Science Translational Medicine·Katharine E HenrySuchi Saria
Jul 28, 2016·BMC Health Services Research·Jessie O OyinlolaAntonis A Kousoulis
Sep 7, 2016·The New England Journal of Medicine·Jørgen VestboUNKNOWN Salford Lung Study Investigators
Oct 26, 2016·Clinical Pharmacology and Therapeutics·H-G EichlerF Koenig
Oct 21, 2016·Journal of Comparative Effectiveness Research·Richard White
Oct 28, 2016·Neuropsychiatric Disease and Treatment·Timothy Peters-StricklandDavid P Walling
Nov 30, 2016·JAMA : the Journal of the American Medical Association·Varun GulshanDale R Webster
Dec 14, 2016·The New England Journal of Medicine·Rachel E ShermanRobert M Califf
Dec 19, 2016·Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research·Julia F SlejkoPeter Milligan
Dec 20, 2016·Journal of Health Economics·Katalin BognarDarius N Lakdawalla
Jun 28, 2017·Patient Preference and Adherence·Elizabeth Whalley BuonoBradi B Granger
Jul 18, 2017·JAMA : the Journal of the American Medical Association·Jonathan P JarowJanet Woodcock
Jul 20, 2017·Clinical Pharmacology and Therapeutics·S R Dorajoo, A Chan
Dec 8, 2017·Clinical Pharmacology and Therapeutics·Rebecca A Miksad, Amy P Abernethy
Dec 24, 2017·Clinical Pharmacology and Therapeutics·Anne C HeatheringtonKarthik Venkatakrishnan

❮ Previous
Next ❯

Citations

Jan 5, 2019·Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan·Kentaro Oniki, Junji Saruwatari
Dec 22, 2019·Clinical Pharmacology and Therapeutics·Sebastiaan C GouloozeCatherijne A J Knibbe
Aug 29, 2020·Therapeutic Innovation & Regulatory Science·Alfredo Aram PuliniGregory Katz
Sep 4, 2020·International Journal of Technology Assessment in Health Care·Karen M FaceyJo de Cock
Dec 12, 2019·Pharmacoepidemiology and Drug Safety·Elodie Baumfeld AndreNancy A Dreyer
Sep 17, 2020·Clinical Pharmacology and Therapeutics·Daniel Hill-McManusDyfrig A Hughes
Aug 1, 2020·PharmacoEconomics·Meenakshi SrinivasanLa'Marcus T Wingate
Jun 30, 2021·Journal of Clinical Pharmacology·John van den Anker, Karel Allegaert
Aug 19, 2021·Clinical and Translational Science·Emese CsokeChristelle Anquez-Traxler

❮ Previous
Next ❯

Software Mentioned

uBiome
PatientsLikeMe
23andMe
PCORnet

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2022 Meta ULC. All rights reserved